Approvals/TGA/ZIMBUS BREEZHALER 114/46/136 indacaterol/glycopyrronium/mometasone furoate 114/46/136 microgram powder for inhalation in capsule with inhaler

Approved

STANDARD

ZIMBUS BREEZHALER 114/46/136 indacaterol/glycopyrronium/mometasone furoate 114/46/136 microgram powder for inhalation in capsule with inhaler

Grand Medical Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: a8cd9989a792cbd5
Company: Grand Medical Pty Ltd
Type: Standard

Approval Details

Approval Id: a8cd9989a792cbd5
Product Name: ZIMBUS BREEZHALER 114/46/136 indacaterol/glycopyrronium/mometasone furoate 114/46/136 microgram powder for inhalation in capsule with inhaler
Artg Id: 385647
Artg Name: ZIMBUS BREEZHALER 114/46/136 indacaterol/glycopyrronium/mometasone furoate 114/46/136 microgram powder for inhalation in capsule with inhaler
Sponsor: Grand Medical Pty Ltd
Company Detail Path: /organization/grand-medical-pty-ltd
Artg Date: 2022-07-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-CMI-01073-1

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a8cd9989a792cbd5

Type

Standard

Back to TGA Approvals